Lusianthridin exhibits anti-migratory activity and inhibits cell viability in human non-small cell lung cancer cell lines (NCI-H460 and NCI-H292) at concentrations above 50 μM; it suppresses Src-STAT3 signaling, promotes c-Myc degradation, and significantly reduces cancer stem cell (CSC) populations and sphere size in H460 and H292 cells.